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Recommendations & Solutions 
 Commercially available, temperature regulated storage 
methods are the ideal solution, but even recreational  
 cooler bags or the use of Styrofoam containers to store 
 drugs, could provide more stability in extreme  
 temperatures (DuBois 2000). 
 
 High temperatures are likely to minimise efficacy or even 
entirely diminish it. 
 
 Low temperatures do not affect most drugs and they will 
be fully functional upon being defrosted. 
 
 Drug choice is dependent on the environment they are 
used in. 
 
 Further research is needed in this area, due to lack of high 
quality data and common protocols. 
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Limitations 
 Studies did not all compare the same drugs or took place under the 
same conditions. 
 Insufficient data to adequately compare common drugs  
 (e.g. adrenaline, amiodarone, GTN) 
 Quality of studies often poor  
 (e.g. design, outcomes, secondary data use) 
 Not all manufacturers specify temperature ranges in their  
 documentation 
Background 
Pre-hospital care is delivered in almost every environment on earth and 
practitioners may encounter extreme heat, extreme cold or rapid 
changes in temperature, which can also affect their equipment and 
drugs. Practitioners may be operating in unfamiliar climates when, for 
example, providing humanitarian aid, on expeditions or providing  
medical cover for oil exploration. In a medical emergency, it is crucial 
that practitioners know that the drugs administered have not degraded 
due to storage conditions.  
Challenges 
 Drugs can degrade or become unusable outside certain temperature ranges 
 Ambient temperature variations  can be significant, even in the United  
 Kingdom 
 No clear guidance on best practice for drug storage in pre-hospital care exists 
 Temperature management technology is often impractical or unavailable 
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